Orient Europharma Co Ltd 4120
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 86.75M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.85
- Dividend Yield (Trailing)
- 8.87%
- Dividend Yield (Forward)
- 8.87%
- Dividend Payment Schedule
- Aug
- Total Yield
- 8.87%
Company Profile
Orient Europharma Co Ltd is a Taiwan-based company engaged in the wholesale of Western Pharmaceutical and Medical Devices. The firm also manufactures drugs and medicines, Beverages, Cleaning Preparations, Cosmetics, Medical Devices, and Other Food Products. Its products cover various therapeutic areas, including the central nervous system, cardiovascular, diabetes, allergy, cosmetics, and health supplements. The company's segments include: Western Pharma BU which includes manufacture and sale of pharmaceutical and cosmetic products; and Nutricare BU includes sale of various nutrition supplements and consumable healthcare products. It derives maximum revenue from Western Pharma BU segment. Geographically, it operates in Taiwan, China, and Southeast Asia.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 800
- Website
- https://www.oepgroup.com
Valuation
|
Metric
|
4120
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.75 |
Price/Sales | 0.85 |
Price/Cash Flow | — |
Price/Earnings
4120
Financial Strength
|
Metric
|
4120
|
|---|---|
Quick Ratio | 0.73 |
Current Ratio | 1.16 |
Interest Coverage | −4.32 |
Quick Ratio
4120
Profitability
|
Metric
|
4120
|
|---|---|
Return on Assets (Normalized) | −4.42% |
Return on Equity (Normalized) | −8.81% |
Return on Invested Capital (Normalized) | −4.90% |
Return on Assets
4120
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|m%>>N#@ | LOCK|$$!G | $71B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|N>F%G%kC | LOCK|!<pZ% | $47B | |||
| Haleon PLC ADR
HLN
| LOCK|f#QmM< | LOCK|cFY | $44B | |||
| Zoetis Inc Class A
ZTS
| LOCK|w@kPNZ$& | LOCK|^&? | $33B | |||
| Viatris Inc
VTRS
| LOCK|Q>#hKd | LOCK|%ck | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|DH | LOCK|Rm | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|b>P<Q> | LOCK|%$y | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|%&TyB%K | LOCK|@dt | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|@D!$D^D | LOCK|r?^v | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|@ZQg^qh | LOCK|>Rk | $2B |
United States